Problems › Should We Buy a Competitor? › Accounting & Advisory Firms
Acquisitions in accounting firms fail on integration far more often than on price, and the integration cost in lost chargeable hours is the number least likely to have been estimated. For accounting firms, this shows up in a particular place. The numbers that carry the answer are 82% realisation rate and 71% billable utilisation, and the complication specific to this industry is that compliance fee compression and inability to shift hours to advisory without reducing statutory output. The general version of this problem and the one you are actually in have different first moves.
Acquisitions in accounting firms fail on integration far more often than on price, and the integration cost in lost chargeable hours is the number least likely to have been estimated. For accounting firms, this shows up in a particular place. The numbers that carry the answer are 82% realisation rate and 71% billable utilisation, and the complication specific to this industry is that compliance fee compression and inability to shift hours to advisory without reducing statutory output. The general version of this problem and the one you are actually in have different first moves.
The case for buying a competitor is usually built on revenue synergies from cross-selling advisory services, which are the least reliable category of benefit and the slowest to arrive given the 34% advisory win rate. Cost synergies from combining compliance work are more predictable, and the honest ones are usually smaller than the model assumes when 82% realisation rates are already under pressure from fee compression.
The number that decides most outcomes is integration cost — merging work-in-progress, staff moves that drop utilisation below 71%, client disruption that risks the 91% compliance retention, and the managing partner attention diverted from the existing 43.2m business for a year or more. It is routinely omitted because it is hard to estimate and does not appear on either firm's accounts.
The disciplined version asks what specifically you get that you could not build or buy more cheaply another way, and what the firm looks like if none of the revenue synergies materialise at the existing 210 fte staff levels.
These three together are the signature. One on its own usually points somewhere else.
✓ The rationale leans on cross-selling advisory services to the acquired compliance clients
✓ Integration is described but no effect on utilisation or realisation rate is costed
✓ The acquisition is partly motivated by compliance fee compression stalling the core revenue
The move that usually makes it worse. Underwriting the deal on revenue synergies from advisory work, which typically arrive late, smaller than modelled, or not at all.
It is for you if you run or finance an accounting firm and the rationale leans on cross-selling to each other's customers. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on an accounting firm. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.
The subject is Pennmark Advisory, a sample company profile used for testing rather than a customer — 43.2m total revenue with 210 fte staff.
Excerpt from a real Percision run · Quick Market Scan · sample company profile
The move. Convert 15,000 compliance hours into $1.9M incremental EBITDA by embedding advisory inside existing client relationships.
| Investment required | $0.8M-$1.2M for 6 FTE conversion specialists (salary + training); funded entirely from existing $7.8M EBITDA within 24-month payback constraint |
| Expected return | Base case: $1.9M incremental EBITDA on $1.0M investment = 1.9× return within 24 months; Low case: $1.4M EBITDA (26% lower pipeline conversion); High case: $2.4M EBITDA (26% higher win rate) |
| Revenue, year 1 | $0.6M incremental advisory revenue (partial year, 6 specialists hired Q2 2027) |
| Revenue, year 2 | $1.9M incremental EBITDA (full-year run rate) |
| Revenue, year 3 | $2.8M incremental EBITDA (additional 4 specialists funded by Year 2 cash flow) |
| Exit criteria | Strategy should be reversed if, within 18 months, (a) advisory win rate falls below 25% for two consecutive quarters, OR (b) compliance retention drops below 88%, OR (c) incremental EBITDA from conversion specialists fails to reach $800K annual run-rate by Month 18 |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Growth Portfolio Framework, one of 29 engagements the platform runs. For accounting firms it works through 82% realisation rate, 71% billable utilisation, 34% advisory win rate and 91% compliance client retention, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.
Twice — once standalone, and once for what it is worth specifically to you. The gap between those is the most you can pay and still create value, and it is usually narrower than expected.
Cost, substantially. They are within your control and can be scheduled. Revenue synergies depend on customers behaving as modelled, which is the assumption most often wrong.
Integration consuming more management attention than anyone budgeted, so that both businesses underperform during the period the deal was supposed to be paying back.
Materially, yes. Compliance fee compression and inability to shift hours to advisory without reducing statutory output — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 82% realisation rate, 71% billable utilisation, 34% advisory win rate, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 82% realisation rate and 71% billable utilisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית